Amdi Receives Nih Radx® Tech Funding To Advance Its 10 Minute Rt-Pcr Point-Of-Care System
04/12/23, 4:01 PM
Location
santa anaIndustry
healthcare
Investors
Nih Ra Dx® Tech Program, National Institute Of Biomedical Imaging And Bioengineering, National Institutes Of Health Rapid Acceleration Of Diagnostics Tech
Autonomous Medical Devices Incorporated (AMDI) announced today that it has been awarded Phase 1 funding from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program in support of its RT-PCR Point-of-Care system. The initial award of $1.2M has the potential for Phase 2 funding pending successful completion of Phase 1. The RADx Tech award is funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and will help AMDI to support the continued development and validation of its novel molecular system as it moves toward product commercialization.
Company Info
Location
10604 s la cienega boulevard
santa ana, california, united states
Additional Info
Autonomous Medical Devices Incorporated (AMDI) is an early-stage, California company focused on developing and manufacturing Autolabs and their associated test discs for human clinical diagnostics. Each of AMDI’s Autolabs are small, portable point-of-care diagnostics devices using breakthrough microfluidics, hardware, and data/cloud connectivity to deliver secure lab quality results in <15 minutes. AMDI has built a world class, multi-disciplinary team of engineers, scientists, clinicians, and database experts and will launch its first Research Use Only (RUO) products in 2023 from its ISO 13485 certified 110,000 square foot facility in Santa Ana, CA.